In a cancer vaccine setback, the drug giant GlaxoSmithKline (GSK) announced yesterday that an immunotherapy it had been testing in a phase III trial had flopped. The company is holding out hope, however, that some patients with a certain genetic signature will still be helped, and the trial is continuing. (1)
So I suppose when the proponents of western medicine critisize homeopathy or acupuncture for “not working for all patients” they are just being… wrong?
You must log in to post a comment.